Design and Development of Xanthone Hybrid for Potent Anti‐Inflammatory Effects: Synthesis and Evaluation
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70477 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Shreyasi Karmakar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam, India. Hauptthemen laut MEDLINE: Xanthones, Anti-Inflammatory Agents, Drug Design. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors extend their appreciation to the Deanship of Scientific Research at King Khalid University for funding this work through a large group Research Pro…, Deanship of Scientific Research, King Khalid University.
Abstract (Originalsprache)
Inflammatory responses, while essential for host defence, can precipitate chronic pathologies when sustained. The polyphenolic entity xanthone is distinguished by its capacity to modulate inflammation, notably via the inhibition of the COX‐2 enzyme and associated inflammatory pathways. Additionally, heterocyclic frameworks such as pyrazole, triazole, and imidazole are recognised for their anti‐inflammatory attributes. This investigation was conducted to engineer and synthesise a series of novel hybrid‐xanthone molecules with enhanced anti‐inflammatory capabilities. Utilising computational docking strategies, these hybrid‐xanthone variants were virtually screened against the COX‐2 enzyme structure (PDB ID:1CX2), and the 10 leading candidates were identified based on their binding affinities. These selected entities were synthesised through an optimised three‐stage synthetic route. Subsequent in vitro assessments were performed using the Egg albumin denaturation assay at incremental concentrations. Complementary in vivo experiments involved the Carrageenan‐induced paw edema protocol in Wistar rats, administered at 200 mg/kg to evaluate the anti‐inflammatory response over a period of 6 h. The best percentage inhibition was shown by compound A127 (3‐(5′(1,2,4‐Triazole)‐pentyloxy)‐1,6,8‐trihydroxy xanthone) , A11 (3‐(1′‐(1,2,4‐Triazole)‐methyloxy)‐1,6,8‐trihydroxy xanthone) and A119 (3‐(1′‐(1,2,4‐Triazole)‐methyloxy)‐1,6,8‐trihydroxy xanthone) as 60 ± 0.31, 58.57 ± 0.023, and 57.14 ± 0.21 respectively. Spectroscopic characterisation of the compounds was achieved through UV, IR, NMR, and Mass spectrometry techniques. The investigation revealed that out of the synthesised cohort, nine compounds exhibited favourable in silico profiles, and half of these manifested substantial anti‐inflammatory efficacy in both in vitro and in vivo models, outperforming the reference standard. These hybrid‐xanthone molecules demonstrated precise COX‐2 inhibition and maintained an acceptable safety margin in vivo, underscoring their therapeutic promise as anti‐inflammatory agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam, India.
- Centre for Biotechnology and Bioinformatics, Dibrugarh University, Dibrugarh, Assam, India.
- Department of Pharmacology, College of Pharmacy, King Khalid University, Abha, Saudi Arabia.
- Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
- Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai, India.
- Department of Chemistry, College of Arts and Sciences, IUBAT-International University of Business Agriculture and Technology, 4 Embankment Drive Road, Sector 10, Uttara Model Town, Dhaka-1230, Bangladesh.
ORCID-Profile: Riya Saikia, Bikram Dhara, Ajoy Kumer
Förderung
- The authors extend their appreciation to the Deanship of Scientific Research at King Khalid University for funding this work through a large group Research Pro…
- Deanship of Scientific Research, King Khalid University
Zitieren
APA
Karmakar, S., Saikia, R., Das, A., Pathak, K., Das, P., Bhuyan, B., Alqahtani, T., Al Shmrany, H., Dhara, B., & Kumer, A. (2025). Design and Development of Xanthone Hybrid for Potent Anti‐Inflammatory Effects: Synthesis and Evaluation. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70477
Vancouver
Karmakar S, Saikia R, Das A, Pathak K, Das P, Bhuyan B, et al. Design and Development of Xanthone Hybrid for Potent Anti‐Inflammatory Effects: Synthesis and Evaluation. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70477
BibTeX
@article{Karmakar2025,
author = {Karmakar, Shreyasi and Saikia, Riya and Das, Aparoop and Pathak, Kalyani and Das, Padmashree and Bhuyan, Biman and Alqahtani, Taha and Al Shmrany, Humood and Dhara, Bikram and Kumer, Ajoy},
title = {Design and Development of Xanthone Hybrid for Potent Anti‐Inflammatory Effects: Synthesis and Evaluation},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70477}
}
EUVIMED